A Flow Process Using Microreactors for the Preparation of a Quinolone Derivative as a Potent 5HT1B> Antagonist

Added on:
8 Feb, 2010

This article describes the continuous flow synthesis of ­6-methoxy-8-(4-methyl-1,4-diazepan-1-yl)-N-(4-morpholinophen-yl)-4-oxo-1,4-dihydroquinoline-2-carboxamide, a potent 5HT1B antagonist developed by AstraZeneca.

  • Zizheng Qian
  • Ian R. Baxendale
  • Steven V. Ley
  • Innovative Technology Centre, Department of Chemistry, University of Cambridge
Read the publication that featured this abstract